Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A V Boddy

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
Clinical Pharmacology and Therapeutics|July 23, 2013
Genetics of cisplatin ototoxicity: confirming the unexplained?A V Boddy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Pharmacogenetics in cancer etiology and chemotherapyA V Boddy, M J Ratain
Journal of Chromatography|March 13, 1992
Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasmaA V Boddy, J R Idle
Cancer Surveys|January 1, 1993
The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicityA V Boddy, J R Idle
Pharmaceutical Research|May 1, 1991
Stereoselectivity in pharmacokinetics: a general theoryR H Levy, A V Boddy
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1991
Application of a linear recirculation model to drug targetingA V Boddy, L J Aarons
Clinical Pharmacokinetics|May 10, 2000
Metabolism and pharmacokinetics of oxazaphosphorinesA V Boddy, S M Yule
Clinical Pharmacokinetics|May 23, 2001
All half-lives are wrong, but some half-lives are usefulJ G Wright, A V Boddy
CNS Drugs|August 14, 2016
RMP-7 : Potential as an Adjuvant to the Drug Treatment of Brain TumoursA V Boddy, H D Thomas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of childrenS M Yule, L Price, A D Pearson, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
Clinical Pharmacology and Therapeutics|July 23, 2013
Genetics of cisplatin ototoxicity: confirming the unexplained?A V Boddy
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 1997
Pharmacogenetics in cancer etiology and chemotherapyA V Boddy, M J Ratain
Journal of Chromatography|March 13, 1992
Combined thin-layer chromatography-photography-densitometry for the quantification of ifosfamide and its principal metabolites in urine, cerebrospinal fluid and plasmaA V Boddy, J R Idle
Cancer Surveys|January 1, 1993
The role of pharmacogenetics in chemotherapy: modulation of tumour response and host toxicityA V Boddy, J R Idle
Pharmaceutical Research|May 1, 1991
Stereoselectivity in pharmacokinetics: a general theoryR H Levy, A V Boddy
Journal of Pharmacokinetics and Biopharmaceutics|June 1, 1991
Application of a linear recirculation model to drug targetingA V Boddy, L J Aarons
Clinical Pharmacokinetics|May 10, 2000
Metabolism and pharmacokinetics of oxazaphosphorinesA V Boddy, S M Yule
Clinical Pharmacokinetics|May 23, 2001
All half-lives are wrong, but some half-lives are usefulJ G Wright, A V Boddy
CNS Drugs|August 14, 2016
RMP-7 : Potential as an Adjuvant to the Drug Treatment of Brain TumoursA V Boddy, H D Thomas
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of childrenS M Yule, L Price, A D Pearson, et al.
Pageof 8